-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

613.P1.60 613. Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation: Poster I

Symposia: Acute Lymphoblastic Leukemias: Therapies Excluding Allogeneic Transplantation Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Anand Ashwin Patel, MD1, Adam S. Duvall, MD1, Caner Saygin, MD1, Howard Weiner2*, Emily Dworkin, PharmD3*, Afsheen Noorani, ANP2*, Jamie Matthews, FNP-BC4*, Rafael Madero Marroquin, MD5, Michael W Drazer, MD, PhD6, Mariam T. Nawas, MD2, Gregory W Roloff, MD2, Satyajit Kosuri, MD2, Michael J. Thirman, MD7, Richard A. Larson, MD1, Olatoyosi Odenike, MD1, Theodore Karrison, PhD2* and Wendy Stock, MD1

1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
2University of Chicago, Chicago, IL
3Department of Pharmacy, University of Chicago, Chicago, IL
4Section of Hematology and Oncology, University of Chicago Medical Center, Chicago, IL
5Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
6Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL
7Section of Hematology/Oncology, The University of Chicago, Chicago, IL, Chicago

Nicolas Lecornec1*, Florence Rabian, MD2*, Marie-Emilie Dourthe, MD, PhD1,3*, Florian Chevillon, MD2*, Karima Yakouben, MD1*, Delphine Chaillou1*, Sophie Caillat-Zucman, MD4*, Alexis Cuffel5*, Emmanuelle Lesprit, MD6*, Anne Arnould6*, Jérome Naudin7*, Julie Roupret-Serzec1*, Nathalie Parquet, MD8*, Anne Brignier, MD9*, Valerie Guerin-El Khourouj10*, Elodie Lainey, PhD, PharmD11*, Aurélie Caye-Eude12*, Chloe Arfeuille12*, Emmanuelle Clappier, Pharm.D., Ph.D.9,13*, Rathana Kim, Pharm.D.14*, Stéphanie Mathis, PharmD15*, Marie-Laure Chaix16*, Elie Azoulay17*, Jean-Hugues Dalle, MD, PHD18, Isabelle Madelaine19*, Jerome Larghero20*, André Baruchel, MD, PhD21 and Nicolas Boissel, MD, PhD22,23

1Department of Pediatric Hematology and Immunology, University Hospital Robert Debré, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France
2Hematology Adolescents and Young Adult Unit, Saint-Louis Hospital, APHP, Paris, France, Paris, France
3Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
4Inserm U976 HIPI, Hôpital Saint Louis, Paris, France
5Assistance Publique Hôpitaux De Paris, Saint Louis Hospital, Immunology D, Paris, France
6Robert Debré Hospital, EFS, Paris, France
7HôPital Robert Debré, APHP, Paris, FRA
8Apheresis, Saint-Louis Hospital, APHP, Paris, France
9Saint Louis Hospital, Paris, France
10Laboratory of Immunology, Hôpital Universitaire Robert Debré́, AP-HP and Université Paris Cité, Paris, France
11Robert Debre Hospital, Paris, FRA
12Department of Genetics, University Hospital Robert Debré, Assistance Publique Des Hôpitaux, Paris, France
13INSERM U944/CNRS UMR7212, Institut de Recherche Saint- Louis, Université Paris Cité, Paris, France
14Assistance Publique Des Hopitaux De Paris (AP-HP) - Universite Paris Descartes -, Paris, Ile-de-France, FRA
15Laboratory of Hematology and Flow cytometry, Saint Louis Hospital, APHP, Paris, France
16Laboratory of Virology, Saint Louis Hospital, APHP, Paris, France
17Médecine Intensive Réanimation, Hôpital Saint Louis, AP-HP, Paris, France
18Department of Pediatric Hematology and Immunology, Robert-Debré Academic Hospital ,, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France
19Pharmacy department, Saint-Louis Hospital, APHP, Paris, France
20Cell Therapy Unit, Saint-Louis Hospital, APHP, Paris, France
21Department of Pediatric Hematology and Immunology,, University Hospital Robert Debré, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France
22Institut Universitaire d'Hématologie, EA-3518, University Hospital Saint-Louis, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France
23Hematology Adolescents and Young Adult Unit, Saint-Louis Hospital, APHP, Paris, France, Paris Cedex 10, Paris, France

Marie Balsat, MD1*, Corentin Orvain2*, Jean-François Benoist3*, Nicolas De Roux4*, Thibaut Leguay, MD5*, Françoise Huguet, MD6*, Patrice Chevallier, MD, PhD7, Cendrine Josson8*, Christine Bain-Wendlinger8*, Yosr Hicheri, MD9*, Anne Thiebaut, MD10*, Martine Escoffre-Barbe, MD11*, Thomas Cluzeau, MD, PhD12, Florence Pasquier, MD, PhD13*, Ana Berceanu, MD14*, Florence Van Obbergh15*, Jamilé Frayfer16*, Gaëlle Guillerm, MD17*, Victoria Cacheux18*, Isabelle Plantier, MD19*, Laurence Sanhes, MD20*, Chantal Himberlin21*, Jacques Vargaftig, MD, PhD22*, Sabine Tricot23*, Yves Chalandon24, Carlos Graux25*, Véronique Lheritier26*, Hervé Dombret, MD, PhD27, Hunault-Berger Mathilde28* and Nicolas Boissel, MD, PhD29

1Clinical Hematology Department, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France, Lyon, France
2Maladies du Sang, CHU d’Angers, Angers, France
3Biochemistry Department, Hôpital Universitaire Necker Enfants Malades, Paris, France
4Laboratoire de Biochimie-Hormonologie, Hôpital Robert Debré, Paris, France
5Hematology, CHU Bordeaux, Hôpital du Haut-Lévêque, Pessac, France
6Hematology Department, Institut Universitaire du Cancer-Oncopole & CHU de Toulouse, Toulouse, France
7Hematology Department, Nantes University Hospital, Nantes, France
8KCAS Bio SAS, Lyon, France
9Department of Hematology, Institut Paoli-Calmettes, Marseille, France
10CHU Grenoble, Grenoble, France
11Hematology department, Hôpital de Pontchaillou, Rennes, France
12Department for Clinical Hematology, Nice University Hospital, Nice, France
13Gustave Roussy, VILLEJUIF, France
14Department of Clinical Hematology, CHU de Besançon, Besançon, France
15Centre Hospitalier de Jolimont, La Louviere, Belgium
16Hematology Department, Grand Hôpital de l'Est Francilien, Meaux, France
17Service d'hématologie, Hôpital Morvan, CHRU Brest, Brest, France
18CHU Estaing, Clermont Ferrand, France
19Hopital Victor Provo, Roubaix, France
20Centre Hospitalier Perpignan, Perpignan, France
21Hôpital Robert Debré, Reims, France
22Institut Curie - Site Saint Cloud, Saint-Cloud, France
23Centre Hospitalier De Valenciennes, Valenciennes, France
24Division of Oncology and Hematology, Univ. Hospital of Geneva, Geneva, Switzerland
25CHU UCL Namur - site Godinne, Yvoir, Belgium
26Service d’Hématologie Coordination GRAALL, HCL, Hôpital Lyon Sud, Pierre Bénite, France
27Hôpital St Louis, Paris, France
28CHU Angers, Angers, France
29Hôpital Saint-Louis, Paris, France

Julie Ma, MD1, Annie Luong2*, Andrew Doan, MD1,3*, Tsen Yin Lin2*, Anh Duong2*, Miguel Villa1* and Chintan Parekh, MD1,3

1Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA
2The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, CA
3University of Southern California Keck School of Medicine, Los Angeles, CA

Anjali Cremer1,2,3*, Maher Hanoun, MD, PhD4*, Ralph Wäsch5, Simon Raffel, MD6*, Klaus Wethmar, MD7*, Andreas Viardot, MD, PhD8, Walter Fiedler, MD9, Knut Wendelin10*, Lore Marretta11*, Wolfram Jung12*, Roland Schroers, MD13*, Vladan Vucinic, MD14*, Monika Brüggemann, MD15*, Stefan Schwartz, MD16*, Hubert Serve, MD2,3,17 and Nicola Goekbuget, MD18

1Department of Medicine II, Hematology/Oncology, Goethe University Hospital, Frankfurt, Germany
2German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Frankfurt, Germany
3Frankfurt Cancer Institute (FCI), Frankfurt, Germany
4Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
5Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, Albert Ludwigs University (ALU), Freiburg, Germany, Freiburg, Germany, Freiburg, Germany
6Department of Medicine V, Universität Heidelberg, Heidelberg, Germany
7Department of Medicine A (Hematology, Hemostaseology, Oncology, Pneumology), University Hospital Muenster, Muenster, Germany
8Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
9Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
10Med Clinic 5, Klinikum Nürnberg, Nuernberg, Germany
11Department of Internal Medicine, Vivantes Klinikum Neukölln, Berlin, Germany
12Department of Hematology and Medical Oncology, University Hospital Goettingen, Goettingen, Germany
13Knappschaftskrankenhaus Bochum, University Hospital Bochum, Bochum, Germany
14University Hospital Leipzig, Leipzig, Germany
15University Medical Center Schleswig-Holstein, University Cancer Center Schleswig-Holstein, Kiel, Germany
16Department of Hematology, Oncology and Cancer Immunology (Campus Benjamin Franklin), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany
17Department of Medicine, Hematology/Oncology, Goethe-University Frankfurt, University Hospital, Frankfurt am Main, Germany
18Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany

Anna Torrent, MD1*, Mireia Morgades2*, Susana Barrera3*, Jordi Ribera2*, Beatriz Soriano4*, Pau Montesinos, PhD, MD5,6*, Eulàlia Genescà2*, José González-Campos, M.D.7*, Pere Barba, MD8, Jordi Esteve, MD, PhD9,10, Marta Sitges11*, Maria Paz Queipo De Llano12*, Carmen Botella13*, Clara Maluquer Artigal, MD14*, Irene García-Cadenas, MD15*, Marisa Calabuig16*, Alberto Hernández-Sánchez17*, Laura Torres, MD18*, Isabel Granada, MD2*, Jesus Maria Hernandez Rivas, MD19,20, Alberto Orfao, MD, PhD4* and Josep-Maria Ribera, MD, PhD21,22

1Hematology department, Institut Català D'oncologia-Hospital Germans Trias I Pujol. Josep Carrera, Badalona, Spain
2ICO-Hospital Germans Trias i Pujol, Institut de Recerca contra la Leucèmia Josep Carreras (IJC), Universitat Autònoma de Barcelona, Badalona, Spain
3Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC – University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (Universidad de Salamanca), Salamanca, Spain. IBSAL (Salamanca, Spain), Salamanca, Spain
4Cancer Research Center (IBMCC-CSIC/USAL-IBSAL), Cytometry Service (NUCLEUS) and Department of Medicine, University of Salamanca, Salamanca, Spain
5Hematology, Hospital Universitari I Politécnic La Fe and Programa Español de Tratamientos en Hematología (PETHEMA) Group, Valencia, Spain
6Department of Hematology, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
7Hematology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain, Sevilla, Spain
8Vall d’Hebron Institute of Oncology (VHIO), Department of Hematology, University Hospital Vall d'Hebron, Universitat Autònoma of Barcelona (UAB), Barcelona, Spain
9Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain
10Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain
11Hematology Department, Institut Català d`Oncologia, Girona, ESP
12Hematology Department Hospital Universitario Virgen de la Victoria, Málaga, Spain, Malaga, ESP
13Hospital General Universitario de Alicante, Alicante, Spain
14Hematology Department. Institut Català d’Oncologia, Hospital Duran i Reynals. Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
15Hematology Service, Hospital Santa Creu i Sant Pau, Barcelona, Spain
16Hematology department, Hospital Clínico de Valencia. Instituto de Investigación Sanitaria INCLIVA de Valencia, Valencia, Spain., Valencia, Spain
17Departmente of Hematology, University Hospital Salamanca, Barcelona, Spain
18Hematology department, Hospital Universitario la Fe de Valencia, Valencia, Spain., Valencia, Spain
19Servicio de Hematología, Hospital Universita­rio de Salamanca, Universidad de Salamanca, Salamanca, Spain
20Department of Medicine, University of Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), University of Salamanca – Cancer Research Center of Salamanca (IBMCC, USAL-CSIG), Salamanca, Spain
21Ico-Hospital Universitari Germans Trias Y Pujol, Badalona, Barcelona, ESP
22Josep Carreras Leukemia Research Institute, Badalona, Barcelona, Spain., Badalona, Spain

Kate D. Westmoreland, MD1,2*, Zachary L Taylor, PhD3,4*, Tamara P. Miller, MD, MSCE5,6, Ashley Chavana7*, Karen R Rabin, MD, PhD8,9, Austin L Brown, PhD, MPH10, Melanie Brooke Bernhardt, MS, PharmD11*, Eric S. Schafer, MD, MHS8,9, Maureen M. O'Brien, MD12, Sharon M. Castellino, MD, MSc5,6 and Laura B. Ramsey, PhD3,4*

1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
2Department of Pediatrics, Division of Pediatric Hematology-Oncology, University of North Carolina, Chapel Hill, NC
3Cancer and Blood Disease Institute, Division of Translational and Clinical Pharmacology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
4Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH
5Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
6Department of Pediatrics, Division of Hematology, Oncology, and Bone Marrow Transplant, Emory University School of Medicine, Atlanta, GA
7Baylor College of Medicine, Houston, TX
8Department of Pediatrics, Division of Pediatric Hematology/Oncology, Baylor College of Medicine, Houston, TX
9Cancer Center and Division of Pediatric Hematology/Oncology, Texas Children's Hospital, Houston, TX
10Department of Pediatrics, Baylor College of Medicine, Houston, TX
11Department of Pharmacy and Pharmaceutical Science, St. Jude Children’s Research Hospital, Memphis, TN
12Colorado Children's Hospital and the University of Colorado School of Medicine, Aurora, CO

Daniel Nguyen, MD, PhD1, Hagop Kantarjian, MD2, Nicholas J. Short, MD2, Nitin Jain, MD2, Fadi G. Haddad, MD2, Musa Yilmaz, MD2*, Alessandra Ferrajoli, MD2, Tapan M. Kadia, MD2, Yesid Alvarado Valero, MD2, Abhishek Maiti, MBBS3, Marianne Zoghbi2*, Jayastu Senapati, MD, DM, MBBS2, Rebecca Garris2*, Min Zhao4*, Marina Konopleva5, Farhad Ravandi, MBBS6 and Elias Jabbour, MD7

1University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of Texas Health Science Center At Houston, Houston, TX
4The University of Texas MD Anderson Cancer Center, Houston, TX
5Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY
6Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
7Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX

Elias Jabbour, MD1, Gerhard Zugmaier, M.D., Ph.D2, Pilar Martinez Sanchez, M.D.3*, Jose J. Rifon, M.D.4*, Vaibhav Agrawal, M.D.5, Ryan D Cassaday, M.D.6,7*, Thomas Cluzeau, MD, PhD8, Françoise Huguet, MD9*, Vladan Vucinic, MD10*, Boris Böll, MD11*, Anita W. Rijneveld, MD, PhD12, Mar Tormo, MD13, Maher Abdul-Hay, MD14*, Paul R Gordon, M.D.15*, Alessandro Rambaldi16 and Hagop M. Kantarjian, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Amgen Research Munich, Munich, Germany
3Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
4Hematology and Hemotherapy Department, Clínica Universidad de Navarra, Pamplona, Spain
5Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
6Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
7Department of Medicine, University of Washington School of Medicine, Seattle, WA
8Nice University Hospital, Nice, France
9Hematology Department, Institut Universitaire du Cancer-Oncopole & CHU de Toulouse, Toulouse, France
10Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig, Leipzig, Saxony, Germany
11Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne; equal contribution, Cologne, Germany
12Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands
13Department of Hematology and Medical Oncology,, Hospital Clínico Universitario de Valencia. INCLIVA Biomedical Research Institute, Valencia, Spain
14Blood and Marrow Transplantation and Cellular Therapy, Laura and Issac Perlmutter Cancer Center at NYU Langone Health, New York, NY
15Amgen Inc., Thousand Oaks, CA
16Department of Oncology and Hematology, University of Milan and Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy

Jayastu Senapati, MD, DM, MBBS1, Elias Jabbour, MD2, Nitin Jain, MD1, Fadi G. Haddad, MD1, Guillermo Garcia-Manero, MD1, Naval Daver, MD3, Tapan M. Kadia, MD1, Farhad Ravandi, MBBS4, Koji Sasaki, MD1, Courtney D. DiNardo, MD, MSc5, Koichi Takahashi, MD, PhD1, Rebecca Garris1*, Jovitta Jacob, RN6*, Yesid Alvarado Valero, MD1, Guillermo Montalban-Bravo, MD1, Nicholas J. Short, MD1 and Hagop Kantarjian, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX
3MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
6The University of Texas MD Anderson Cancer Center, Houston, TX

Jayastu Senapati, MD, DM, MBBS1, Elias Jabbour, MD2, Nicholas J. Short, MD1, Nitin Jain, MD1, Fadi G. Haddad, MD1, Tapan M. Kadia, MD1, Koji Sasaki, MD1, Yesid Alvarado Valero, MD1, Koichi Takahashi, MD, PhD1, Courtney D. DiNardo, MD, MSc3, Naval Daver, MD4, Guillermo Garcia-Manero, MD1, Farhad Ravandi, MBBS5, Jovitta Jacob, RN6*, Rebecca Garris1* and Hagop Kantarjian, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX
3Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
4MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
6The University of Texas MD Anderson Cancer Center, Houston, TX

Jingliao Zhang, MD1, Junxia Wang1*, Huanshan Guo, MD2*, Tianfeng Liu3*, Xiaoyan Zhang1*, Ranran Zhang1*, Min Ruan, MD1*, Lixian Chang, PhD4*, Xiaoming Liu, MD1*, Yuanyuan Ren, MD1*, Xia Chen5*, Hengbang Wang, PhD6*, Zi Chen, MD, PhD6*, Yingchi Zhang4*, Yumei Chen1*, Li Zhang4*, Ye Guo1*, Fang Liu, MD7*, Xiaojuan Chen, MD8*, Yao Zou9*, Wenyu Yang, MD7*, Yifan Zhai, MD, PhD2,6,10 and Xiaofan Zhu, MD1*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
2Guangzhou Healthquest Pharma Co., Ltd., Guangzhou, China
3State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
4State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC, Tianjin, China
5Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, Tianjin, China
6Ascentage Pharma (Suzhou) Co., Ltd., Suzhou, China
7Department of Pediatric Hematology and Oncology, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences& Peking Union Medical College, Tianjin, China
8Department of Pediatric Hematology and Oncology, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
9State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
10Ascentage Pharma Group Inc., Rockville, MD

Marko Kavcic, MD, PhD1*, Volkan Hazar, MD, MsC2*, Anna Mohás, MD3*, Veronika Enzsöl, MD4*, Andrea Reyes, MD5*, Boryana Avramova, MD PhD6*, Tomaz Prelog, MD, PhD1*, Mirella Ampatzidou, MD, PhD7*, Koray Yalcin, MD8*, Monica Makiya9*, Sophia Polychronopoulou, MD, PhD7*, Juan Tordecilla, MD10*, Janez Jazbec, MD, PhD1* and Daniel J Erdelyi, MD, PhD3*

1University Medical Centre, Ljubljana, SVN
2Memorial Health Group Medstar Yildiz Hospital, Antalya, Turkey
3Pediatric Center, Semmelweis University, Budapest, Hungary
4Heim Pál Children Hospital, Budapest, Hungary
5Hospital Robert de Rio, Santiago, Chile
6University Hospital “Tsaritsa Johanna-ISUL”, Sofia, Bulgaria
7Department of Pediatric Hematology Oncology, Aghia Sophia Children’s Hospital, Athens, Greece
8Bahcesehir University Medical Park Göztepe Hospital, Istanbul, Turkey
9Hospital Italiano de Buenos Aires, Buenos Aires, CH, ARG
10Clinica Santa Maria, Santiago, Chile

Omali Pitiyarachchi, MBBS, BSc, FRACP1*, Madeleine T King, PhD2*, Shane Gangatharan, MBBS, FRACP, FRCPA3*, Michael Osborn, MBBS, FRACP, FRCPA4*, Ashley P Ng, PhD, MBBS, FRACP, FRCPA5*, Shaun Fleming, MBBS, FRACP, FRACPA6*, Pasquale Fedele, MBBS, PhD7*, Toby N Trahair, BSc(Med) hons, MBBS, PhD, FRACP8*, John Casey, MBBS, BPharm(hons), FRACP, FRCPA, MHM9*, Sally Mapp, MD10*, Carol CY Cheung, PhD, FRACP, FRCPA, MBBS11, Tasman Armytage, MBBS, BSc, FRACP, FRCPA12*, Philip McCloud, PhD13*, Peter Button13*, Leesa Rowley14*, Stephen Robert Larsen, MBBS PhD FRACP FRCPA15, Peter Presgrave, MBBS16, John Kwan, MBBS, FRACP, FRCPA17*, Samuel Bennett, MBBS, FRACP, FRCPA18*, Chun Yew Fong, MBBS, FRACP, FRCPA, PhD19*, Luciano Dalla-Pozza, MD20 and Matthew Greenwood, MBBS, FRACP, FRCPA21

1School of Biomedical Sciences, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia
2The University of Sydney, Sydney, Australia
3Fiona Stanley Hospital, Murdoch, AUS
4Royal Adelaide Hospital, Adelaide, Australia
5Peter MacCallum Cancer Centre, Melbourne, Australia
6Department of Malignant Haematology & Stem Cell Transplantation, The Alfred Hospital, Melbourne, VIC, Australia
7Monash Hospital, Melbourne, Australia
8Paediatric Haematology & Oncology, Kids Cancer Center, Sydney Children's Hospital, Kensington, NSW, Australia
9The Townsville Hospital, Townsville, Australia
10Princess Alexandra Hospital, Brisbane, Australia
11Prince of Wales Hospital, Randwick, Australia
12Gosford Hospital, Gosford, Australia
13McCloud Consulting Group, Sydney, Australia
14Australasian Leukaemia & Lymphoma Group, Richmond, AUS
15Royal Prince Alfred Hospital, Camperdown, Australia
16Wollongong Hospital, Wollongong, Australia
17Westmead Hospital, Westmead, NSW, Australia
18Canberra Hospital, Garren, Australia
19Department of Hematology, Austin Health, Heidelberg, VIC, Australia
20The Children's Hospital at Westmead, Westmead, Australia
21Royal North Shore Hospital, Sydney, NSW, Australia

Clarissa Garcia1, Kaylyn Lyons, MD1*, Tian Liu2*, Ilaria Iacobucci, PhD3, Amanda Novak, BS1*, Amy Argabright4*, Alexis Donnelly1*, Julian Grandvallet Contreras, BS2*, Huimin Geng, PhD5*, Sabrina Smith6, Xin Zhou, PhD7*, Markus Müschen, MD8, John Edgar Dick6, Julie R Haines, PhD4*, Angelo D'Alessandro, PhD9, Charles G. Mullighan, MBBS, MSc, MD10, Tzu Phang, PhD1*, M. Eric Kohler, MD, Ph.D11 and Matthew Witkowski, PhD1

1Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO
2Department of Pediatrics, Section of Hematology/Oncology/BMT, University of Colorado Anschutz Medical Campus, Aurora, CO
3St. Jude Children's Research Hospital, Memphis, TN
4Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO
5Department of Laboratory Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
6Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada
7Department of Computational Biology, St Jude Childrens Research Hospital, Memphis, TN
8Center of Molecular and Cellular Oncology, Yale University, New Haven, CT
9Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO
10Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
11Department of Pediatrics- Hematology, Oncology, and Bone Marrow Transplant, University of Colorado Anschutz Medical Campus, Aurora, CO

Yuhang Cheng1*, Xueyan Sun1*, Meijuan Huang, MD1*, Lei Zhao, MD, PhD1*, Jue Wang1*, Hanyu Wang1*, Wanying Liu1*, Shanwei Ye2*, Liang Huang3, Gaoxiang Wang1* and Yang Cao4*

1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China, Wuhan, China
3Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China
4Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, San Diego, CA

Sarvarinder Kaur Gill1, Geeny Lee, PharmD, BCOP2*, Joelle Rubin, APN3*, Shuqi Wang4*, Jamie Koprivnikar, MD3*, Katherine Linder, MD3* and James McCloskey, MD3

1John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
2Department of Pharmacy, Hackensack University Medical Center, Hackensack, NJ
3Department of Leukemia, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
4MD Anderson Cancer Center, Houston, TX

Xu Tan1*, Guo Chen1*, Yingying Ma1*, Maihong Wang1*, Qin Wen, MD1*, Hong Liu1*, Xi Zhang, PhD2,3 and Cheng Zhang, MD, PhD1*

1Army Military Medical University, Chongqing, China
2Affiliated xinqiao Hospital of Army medical University,chongqing ,China, chongqing city, China
3Jinfeng Laboratory, Chongqing, China

Asad Bashey, MD, PhD1, Xu Zhang, PhD2*, H. Kent Holland, MD1*, Lawrence E Morris, MD3, Lizamarie Bachier-Rodriguez1*, Scott R. Solomon, MD3 and Melhem M. Solh, MD3

1BMT Program at Northside Hospital, Atlanta, GA
2Center for Clinical and Transitional Sciences,, University of Texas, Houston, TX
3Blood and Marrow Transplant Group of Georgia, Atlanta, GA

*signifies non-member of ASH